Anthony Doyle

Anthony Doyle is the current Senior Vice President and Chief Financial Officer at BioCryst Pharmaceuticals. Anthony has been in this position for 2 years and 4 months. Prior to this, they were the Chief Financial Officer at Worldwide Clinical Trials for 5 years and 4 months. Anthony also worked as the CFO at World Book (Berkshire Hathaway) for 2 years and 3 months.

Anthony has extensive experience in financial management and oversight. Anthony has a proven track record in creating and implementing financial strategies that have resulted in increased profits and shareholder value. Anthony is a highly skilled negotiator and has a deep understanding of the pharmaceutical industry.

Under Anthony's leadership, BioCryst has been able to achieve significant financial milestones. Anthony has successfully navigated the company through the COVID-19 pandemic and has positioned the company for long-term success. Anthony is a strong leader and an excellent communicator. Anthony is passionate about their work and is committed to delivering extraordinary medicines that help patients live ordinary lives.

Anthony Doyle has a Grad Cert from Dublin City University in Corporate Treasury and a degree in European Business & French from the same school.

The colleagues of Anthony Doyle include the following people: Charlie Gayer, Megan Sniecinski, Yarlagadda S. Babu, Elliott Berger, Alane Barnes, Thomas R. Staab, John Bluth, William P. Sheridan, Stephanie Angelini, and Carol Ohmstede.